TEL: +86-57186608701//81389219/89712897   Email:admin@safecare.com.cn
简体中文简体中文
Home » News » Company News » Announcement on CE Approval of COVID-19 Antigen Rapid Test

Announcement on CE Approval of COVID-19 Antigen Rapid Test

Views: 2     Author: Site Editor     Publish Time: 2022-04-18      Origin: Site

The COVID-19 Antigen Rapid Test (Saliva) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19.

This test is intended for home use with self-collected saliva samples in individuals aged 18 and older.  Sampling from anyone under the age of 18 should be performed under the guidance of an adult. People who are unable to carry out the test on their own should seek support.

This test utilizes the lateral flow immunoassay technology for the detection of nucleocapsid protein antigen in individuals with known or suspected COVID-19.

Positive results are indicative of the presence of SARS-CoV-2. Individuals who test positive should self-isolate and seek additional care from their healthcare provider. Positive results do not rule out bacterial infection or co-infection with other viruses.

Negative results do not preclude SARS-CoV-2 infection. Individuals who test negative and continue to experience COVID-like symptoms should seek follow up care from their healthcare provider.

Package Available: 1Test/Box; 25Tests/Box

Welcome to inquire for details!

2022.4.25修改 产品宣传页_00.jpg

Quick Links

Product Category

Contact Us

Address : Bldg 2, No 2628 Yuhang

tang RD,Hangzhou, 311121 China

Tel: (+86) 57186608701//81389219
/89712897
Email: admin@safecare.com.cn
Send Us A Message
 Copyrights 2022 Safecare Biotech(Hangzhou)Co.,Ltd